Latest advances and current challenges in the treatment of multiple myeloma.

Nature Reviews. Clinical Oncology
Anuj MahindraKenneth Anderson

Abstract

Effectively treating patients with multiple myeloma is challenging. The development of therapeutic regimens over the past decade that incorporate the proteasome inhibitor bortezomib and the immunomodulatory drugs thalidomide and lenalidomide has been the cornerstone of improving the outcome of patients with myeloma. Although these treatment regimens have improved patient survival, nearly all patients eventually relapse. Our improved understanding of the biology of the disease and the importance of the microenvironment has translated into ongoing work to help overcome the challenge of relapse. Several classes of agents including next-generation proteasome inhibitors, immunomodulatory agents, selective histone-deacetylase inhibitors, antibody and antitumor immunotherapy approaches are currently undergoing preclinical and clinical evaluation. This Review provides an update on the latest advances in the treatment of multiple myeloma. In particular, we focus on novel therapies including modulating protein homeostasis, kinases inhibitors, targeting accessory cells and cytokines, and immunomodulatory agents. A discussion of the challenges associated with these therapeutic approaches is also presented.

References

Jun 27, 2003·The New England Journal of Medicine·Paul G RichardsonKenneth C Anderson
Apr 6, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philip R GreippJan Westin
Jun 7, 2005·Proceedings of the National Academy of Sciences of the United States of America·Teru HideshimaKenneth C Anderson
Jun 17, 2005·The New England Journal of Medicine·Paul G RichardsonUNKNOWN Assessment of Proteasome Inhibition for Extending Remissions (APEX) Investigators
Sep 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A Keith Stewart, Rafael Fonseca
Dec 21, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vincent RajkumarUNKNOWN Eastern Cooperative Oncology Group
Sep 7, 2006·Genes, Chromosomes & Cancer·Wee J ChngRafael Fonseca
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Craig D PeacockWilliam Matsui
Apr 25, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kumar SukhdeoDaniel R Carrasco
Aug 8, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert Z OrlowskiJean-Luc Harousseau
Oct 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Paola NeriNoopur Raje
Nov 23, 2007·The New England Journal of Medicine·Meletios DimopoulosUNKNOWN Multiple Myeloma (010) Study Investigators
Nov 23, 2007·The New England Journal of Medicine·Donna M WeberUNKNOWN Multiple Myeloma (009) Study Investigators
Dec 1, 2007·Journal of Immunotherapy·Susann SzmaniaFrits van Rhee
Dec 21, 2007·Leukemia·A PalumboUNKNOWN International Myeloma Working Group
Feb 12, 2008·Blood·Donald LavelleJoseph Desimone
Aug 30, 2008·The New England Journal of Medicine·Jesús F San MiguelUNKNOWN VISTA Trial Investigators
Apr 22, 2009·The Journal of Clinical Investigation·Jing QingAvi Ashkenazi
May 7, 2009·Blood·Mariateresa FulcinitiNikhil C Munshi
May 8, 2009·The Journal of Clinical Investigation·Yaron Hadari, Joseph Schlessinger
Jun 6, 2009·Blood·Jatin J ShahRobert Z Orlowski
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroshi IkedaKenneth C Anderson
Jun 24, 2009·British Journal of Haematology·Christine ChenVincent Rajkumar
Jun 25, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Masanori NojimaYasuhisa Shinomura
Jul 28, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M VarettoniM Lazzarino
Sep 2, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martha Q LacyS Vincent Rajkumar
Sep 4, 2009·The New England Journal of Medicine·Charles M RudinJennifer A Low

❮ Previous
Next ❯

Citations

Jul 16, 2013·Leukemia Research·Li BaoXiaojun Huang
Jun 30, 2012·Journal of the National Cancer Institute·Anuj Mahindra, Kenneth C Anderson
Oct 2, 2012·The Journal of Clinical Investigation·W Michael Kuehl, P Leif Bergsagel
Feb 27, 2014·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sarah M FrancisJohn E Thompson
Jan 23, 2014·ELife·Jin Ye
Nov 11, 2014·The Journal of Clinical Investigation·Tobias DechowUlrich Keller
Jul 24, 2014·Protein Engineering, Design & Selection : PEDS·Joseph SwiftDaniel Christ
Dec 10, 2013·Journal of Hematology & Oncology·Joshua KellnerZihai Li
Mar 19, 2016·BioMed Research International·Mariateresa FulcinitiAbdel Kareem Azab
Aug 18, 2012·Leukemia & Lymphoma·Giada Bianchi, Irene M Ghobrial
Jul 21, 2015·Expert Opinion on Therapeutic Targets·Jianfeng GuoCaitriona M O'Driscoll
Jul 18, 2012·Expert Opinion on Investigational Drugs·Steffan T NawrockiJennifer S Carew
Aug 5, 2015·Proceedings of the National Academy of Sciences of the United States of America·Amy WuRobert H Austin
Apr 8, 2015·Pharmacology & Therapeutics·Lixia WangWenyi Wei
Jun 5, 2013·Critical Reviews in Oncology/hematology·André Veillette, Huaijian Guo
May 23, 2014·Immunologic Research·Timothy R RoseanSiegfried Janz
Aug 27, 2015·Scientific Reports·Virginie Follin-ArbeletHeidi Kiil Blomhoff
Jul 23, 2013·European Journal of Haematology·Toril HolienAnders Sundan
Apr 17, 2013·European Journal of Haematology·Konstantinos DimopoulosKirsten Grønbæk
Sep 23, 2014·Cellular Microbiology·Christian Münz
Dec 10, 2015·BioMed Research International·Wen-Chi Yang, Sheng-Fung Lin
Mar 19, 2014·Clinical Lymphoma, Myeloma & Leukemia·Ravi VijJeffrey Wolf
Jun 30, 2015·Experimental Hematology·Naoya MimuraKenneth C Anderson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.